Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?

Ewer MS, Lenihan DJ.

Nat Clin Pract Oncol. 2008 Apr;5(4):192-3. doi: 10.1038/ncponc1045. Epub 2008 Jan 22. No abstract available.

PMID:
18212766
2.

Lapatinib: a dual tyrosine kinase inhibitor for metastatic breast cancer.

Paul B, Trovato JA, Thompson J.

Am J Health Syst Pharm. 2008 Sep 15;65(18):1703-10. doi: 10.2146/ajhp070646. Review.

PMID:
18768996
3.

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

Medina PJ, Goodin S.

Clin Ther. 2008 Aug;30(8):1426-47. doi: 10.1016/j.clinthera.2008.08.008. Review.

PMID:
18803986

Supplemental Content

Support Center